These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1531 related items for PubMed ID: 20496301

  • 1. Mono- and combination therapy of long-acting bronchodilators and inhaled corticosteroids in advanced COPD.
    Ohar JA, Donohue JF.
    Semin Respir Crit Care Med; 2010 Jun; 31(3):321-33. PubMed ID: 20496301
    [Abstract] [Full Text] [Related]

  • 2. Long-acting bronchodilator therapy for the treatment of chronic obstructive pulmonary disease.
    Chen AM, Bollmeier SG, Finnegan PM.
    Ann Pharmacother; 2008 Dec; 42(12):1832-42. PubMed ID: 18957624
    [Abstract] [Full Text] [Related]

  • 3. Benefits and risks of adjunctive inhaled corticosteroids in chronic obstructive pulmonary disease: a meta-analysis.
    Sobieraj DM, White CM, Coleman CI.
    Clin Ther; 2008 Aug; 30(8):1416-25. PubMed ID: 18803985
    [Abstract] [Full Text] [Related]

  • 4. The short, the long and the "ultra-long": why duration of bronchodilator action matters in chronic obstructive pulmonary disease.
    Beeh KM, Beier J.
    Adv Ther; 2010 Mar; 27(3):150-9. PubMed ID: 20411368
    [Abstract] [Full Text] [Related]

  • 5. Pharmacologic treatments for chronic obstructive pulmonary disease: a mixed-treatment comparison meta-analysis.
    Baker WL, Baker EL, Coleman CI.
    Pharmacotherapy; 2009 Aug; 29(8):891-905. PubMed ID: 19637942
    [Abstract] [Full Text] [Related]

  • 6. Enhanced persistence with tiotropium compared with other respiratory drugs in COPD.
    Breekveldt-Postma NS, Koerselman J, Erkens JA, Lammers JW, Herings RM.
    Respir Med; 2007 Jul; 101(7):1398-405. PubMed ID: 17368011
    [Abstract] [Full Text] [Related]

  • 7. Effects of inhaled corticosteroids in monotherapy or combined with long-acting {beta}2-agonists on mortality among patients with chronic obstructive pulmonary disease.
    Cyr MC, Beauchesne MF, Lemière C, Aaron SD, Blais L.
    Ann Pharmacother; 2010 Apr; 44(4):613-22. PubMed ID: 20233915
    [Abstract] [Full Text] [Related]

  • 8. Survival among COPD patients using fluticasone/salmeterol in combination versus other inhaled steroids and bronchodilators alone.
    Mapel DW, Nelson LS, Lydick E, Soriano J, Yood MU, Davis KJ.
    COPD; 2007 Jun; 4(2):127-34. PubMed ID: 17530506
    [Abstract] [Full Text] [Related]

  • 9. [Practice guideline 'Medical treatment of COPD'].
    Dekhuijzen PN, Broeders ME, Tuut MK, Grol MH.
    Ned Tijdschr Geneeskd; 2008 Jun 28; 152(26):1465-8. PubMed ID: 18666664
    [Abstract] [Full Text] [Related]

  • 10. Indacaterol, a novel inhaled, once-daily, long-acting beta2-agonist for the treatment of obstructive airways diseases.
    Beeh KM, Beier J.
    Adv Ther; 2009 Jul 28; 26(7):691-9. PubMed ID: 19609496
    [Abstract] [Full Text] [Related]

  • 11. Optimizing maintenance therapy for chronic obstructive pulmonary disease: strategies for improving patient-centered outcomes.
    Hanania NA.
    Clin Ther; 2007 Oct 28; 29(10):2121-33. PubMed ID: 18042470
    [Abstract] [Full Text] [Related]

  • 12. The impact of inhaled corticosteroid and long-acting beta-agonist combination therapy on outcomes in COPD.
    Hanania NA.
    Pulm Pharmacol Ther; 2008 Oct 28; 21(3):540-50. PubMed ID: 18280761
    [Abstract] [Full Text] [Related]

  • 13. [Friend or foe: combination therapy with inhaled corticosteroids and long-acting beta2-agonists in chronic obstructive pulmonary disease (COPD)].
    Gillissen A, Gessner C, Hoheisel G, Juergens U.
    Pneumologie; 2008 Jul 28; 62(7):430-7. PubMed ID: 18398787
    [Abstract] [Full Text] [Related]

  • 14. A double-blind crossover study comparing the safety and efficacy of three weeks of Flu/Sal 250/50 bid plus albuterol 180 ug prn q4 hours to Flu/Sal 250/50 bid plus albuterol/Ipratropium bromide 2 puffs prn q4 hours in patients with chronic obstructive pulmonary disease.
    Balkissoon R, Make B.
    COPD; 2008 Aug 28; 5(4):221-7. PubMed ID: 18671147
    [Abstract] [Full Text] [Related]

  • 15. Survival with tiotropium compared to long-acting Beta-2-agonists in Chronic Obstructive Pulmonary Disease.
    Gershon AS, Wang L, To T, Luo J, Upshur RE.
    COPD; 2008 Aug 28; 5(4):229-34. PubMed ID: 18671148
    [Abstract] [Full Text] [Related]

  • 16. Effect of long-acting beta-agonists on the frequency of COPD exacerbations: a meta-analysis.
    Wang J, Nie B, Xiong W, Xu Y.
    J Clin Pharm Ther; 2012 Apr 28; 37(2):204-11. PubMed ID: 21740451
    [Abstract] [Full Text] [Related]

  • 17. Inhaled corticosteroids as additional treatment in alpha-1-antitrypsin-deficiency-related COPD.
    Corda L, Bertella E, La Piana GE, Boni E, Redolfi S, Tantucci C.
    Respiration; 2008 Apr 28; 76(1):61-8. PubMed ID: 18319586
    [Abstract] [Full Text] [Related]

  • 18. [Bronchodilators in chronic obstructive pulmonary disease (COPD)].
    Gillissen A, Buhl R, Rabe KF, Vogelmeier C, Welte T.
    Med Klin (Munich); 2005 May 13; 100(5):246-54. PubMed ID: 15902378
    [Abstract] [Full Text] [Related]

  • 19. Long-acting beta-agonists and their association with inhaled corticosteroids in COPD.
    Fuso L, Mores N, Valente S, Malerba M, Montuschi P.
    Curr Med Chem; 2013 May 13; 20(12):1477-95. PubMed ID: 23409722
    [Abstract] [Full Text] [Related]

  • 20. Innovations to achieve excellence in COPD diagnosis and treatment in primary care.
    Fromer L, Barnes T, Garvey C, Ortiz G, Saver DF, Yawn B.
    Postgrad Med; 2010 Sep 13; 122(5):150-64. PubMed ID: 20861599
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 77.